Although GBMs and breast cancer are estrogen-responsive tumors, they have different biological contexts in which the role of EZH2 and the mechanisms controlling its expression may be different, as has been suggested in neoplastic cells (14). The gene discussed is EZH2; the disease is breast carcinoma.